• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物作为潜在的 SARS-CoV-2 M 抑制剂:药物发现。

Natural-like products as potential SARS-CoV-2 M inhibitors: drug discovery.

机构信息

Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia, Egypt.

Chemistry of Medicinal Plants Department, National Research Centre, El-Tahrir St, Dokki, Giza, Egypt.

出版信息

J Biomol Struct Dyn. 2021 Sep;39(15):5722-5734. doi: 10.1080/07391102.2020.1790037. Epub 2020 Jul 8.

DOI:10.1080/07391102.2020.1790037
PMID:32643529
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7443551/
Abstract

In December 2019, a COVID-19 epidemic was discovered in Wuhan, China, and since has disseminated around the world impacting human health for millions. Herein, drug discovery approaches have been utilized to identify potential natural products (NPs) as Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) main protease (M) inhibitors. The MolPort database that contains over 100,000 NPs was screened and filtered using molecular docking techniques. Based on calculated docking scores, the top 5,000 NPs/natural-like products (NLPs) were selected and subjected to molecular dynamics (MD) simulations followed by molecular mechanics-generalized Born surface area (MM-GBSA) binding energy calculations. Combined 50 ns MD simulations and MM-GBSA calculations revealed nine potent NLPs with binding affinities (Δ) > -48.0 kcal/mol. Interestingly, among the identified NLPs, four bis([1,3]dioxolo)pyran-5-carboxamide derivatives showed Δ > -56.0 kcal/mol, forming essential short hydrogen bonds with HIS163 and GLY143 amino acids via dioxolane oxygen atoms. Structural and energetic analyses over 50 ns MD simulation demonstrated NLP-M complex stability. Drug-likeness predictions revealed the prospects of the identified NLPs as potential drug candidates. The findings are expected to provide a novel contribution to the field of COVID-19 drug discovery.Communicated by Ramaswamy H. Sarma.

摘要

2019 年 12 月,一种 COVID-19 疫情在中国武汉被发现,此后已在全球范围内传播,影响了数百万人的健康。在此,利用药物发现方法来鉴定潜在的天然产物(NPs)作为严重急性呼吸系统综合症冠状病毒 2(SARS-CoV-2)主要蛋白酶(M)抑制剂。利用分子对接技术筛选和过滤了 MolPort 数据库,该数据库包含超过 100,000 种 NPs。基于计算出的对接评分,选择了前 5,000 种 NPs/天然类似物(NLPs)进行分子动力学(MD)模拟,然后进行分子力学-广义 Born 表面积(MM-GBSA)结合能计算。50ns MD 模拟和 MM-GBSA 计算的组合结果显示,有 9 种具有结合亲和力(Δ)> -48.0kcal/mol 的强 NLPs。有趣的是,在所鉴定的 NLPs 中,有 4 种双([1,3]二氧杂环戊烷-5-甲酰胺衍生物显示出 Δ> -56.0kcal/mol,通过二氧戊环氧原子与 HIS163 和 GLY143 氨基酸形成必需的短氢键。超过 50ns MD 模拟的结构和能量分析表明,NLP-M 复合物是稳定的。药物相似性预测显示,所鉴定的 NLPs 有望成为潜在的药物候选物。这些发现有望为 COVID-19 药物发现领域提供新的贡献。由 Ramaswamy H. Sarma 交流。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/7443551/a3689bdbe6de/TBSD_A_1790037_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/7443551/a3689bdbe6de/TBSD_A_1790037_UF0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ccc/7443551/a3689bdbe6de/TBSD_A_1790037_UF0001_C.jpg

相似文献

1
Natural-like products as potential SARS-CoV-2 M inhibitors: drug discovery.天然产物作为潜在的 SARS-CoV-2 M 抑制剂:药物发现。
J Biomol Struct Dyn. 2021 Sep;39(15):5722-5734. doi: 10.1080/07391102.2020.1790037. Epub 2020 Jul 8.
2
drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors.药物重定位和分子动力学解析出潜在的 SARS-CoV-2 主要蛋白酶抑制剂。
J Biomol Struct Dyn. 2021 Sep;39(15):5756-5767. doi: 10.1080/07391102.2020.1791958. Epub 2020 Jul 20.
3
In Silico Evaluation of Prospective Anti-COVID-19 Drug Candidates as Potential SARS-CoV-2 Main Protease Inhibitors.计算机模拟评估有潜力的抗 COVID-19 药物候选物作为潜在的 SARS-CoV-2 主要蛋白酶抑制剂。
Protein J. 2021 Jun;40(3):296-309. doi: 10.1007/s10930-020-09945-6. Epub 2021 Jan 2.
4
Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study.芦丁及黄酮类似物作为潜在的新型冠状病毒主要蛋白酶抑制剂:计算机辅助药物发现研究
J Mol Graph Model. 2021 Jun;105:107904. doi: 10.1016/j.jmgm.2021.107904. Epub 2021 Mar 20.
5
In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.基于计算机的药物发现:香料中的主要代谢物可作为 SARS-CoV-2 主蛋白酶抑制剂。
Comput Biol Med. 2020 Nov;126:104046. doi: 10.1016/j.compbiomed.2020.104046. Epub 2020 Oct 8.
6
validation of coumarin derivatives as potential inhibitors against Main Protease, NSP10/NSP16-Methyltransferase, Phosphatase and Endoribonuclease of SARS CoV-2.验证香豆素衍生物作为潜在抑制剂对 SARS-CoV-2 的主要蛋白酶、NSP10/NSP16-甲基转移酶、磷酸酶和内切核糖核酸酶的抑制作用。
J Biomol Struct Dyn. 2021 Nov;39(18):7306-7321. doi: 10.1080/07391102.2020.1808075. Epub 2020 Aug 24.
7
Blue Biotechnology: Computational Screening of Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition.蓝色生物技术:基于计算的膜海松二萜类化合物对 SARS-CoV-2 主蛋白酶抑制作用的筛选
Mar Drugs. 2021 Jul 13;19(7):391. doi: 10.3390/md19070391.
8
In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M) Inhibitors.基于红海中无脊椎动物的萜类化合物的计算机挖掘,寻找 SARS-CoV-2 主蛋白酶(M)抑制剂。
Molecules. 2021 Apr 5;26(7):2082. doi: 10.3390/molecules26072082.
9
Potential of NO donor furoxan as SARS-CoV-2 main protease (M) inhibitors: analysis.硝酮呋咱类一氧化氮供体作为 SARS-CoV-2 主蛋白酶(M)抑制剂的潜力:分析。
J Biomol Struct Dyn. 2021 Sep;39(15):5804-5818. doi: 10.1080/07391102.2020.1790038. Epub 2020 Jul 8.
10
Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.从天然来源开发针对冠状病毒蛋白酶的有效治疗分子。
Int J Mol Sci. 2021 Aug 30;22(17):9431. doi: 10.3390/ijms22179431.

引用本文的文献

1
Unraveling Cordia myxa's anti-malarial potential: integrative insights from network pharmacology, molecular modeling, and machine learning.解析黄麻的抗疟潜力:网络药理学、分子建模和机器学习的综合见解。
BMC Infect Dis. 2024 Oct 19;24(1):1180. doi: 10.1186/s12879-024-10078-9.
2
Alpha and gamma mangostins inhibit wild-type B SARS-CoV-2 more effectively than the SARS-CoV-2 variants and the major target is unlikely the 3C-like protease.α-和γ-山竹黄酮对野生型B型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抑制作用比对SARS-CoV-2变异株更有效,且主要靶点不太可能是3C样蛋白酶。
Heliyon. 2024 May 27;10(11):e31987. doi: 10.1016/j.heliyon.2024.e31987. eCollection 2024 Jun 15.
3
Discovering New Natural Products Using Metabolomics-Based Approaches.
利用基于代谢组学的方法发现新的天然产物。
Adv Exp Med Biol. 2023;1439:185-224. doi: 10.1007/978-3-031-41741-2_8.
4
In Silico Models for Anti-COVID-19 Drug Discovery: A Systematic Review.用于抗COVID-19药物发现的计算机模拟模型:一项系统综述。
Adv Pharmacol Pharm Sci. 2023 Jun 15;2023:4562974. doi: 10.1155/2023/4562974. eCollection 2023.
5
Identification of and Mechanistic Insights into SARS-CoV-2 Main Protease Non-Covalent Inhibitors: An In-Silico Study.鉴定 SARS-CoV-2 主蛋白酶非共价抑制剂及其作用机制:一项计算机研究。
Int J Mol Sci. 2023 Feb 20;24(4):4237. doi: 10.3390/ijms24044237.
6
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies.用于治疗新冠肺炎的新型药物设计:临床前研究的系统综述
Can J Infect Dis Med Microbiol. 2022 Sep 25;2022:2044282. doi: 10.1155/2022/2044282. eCollection 2022.
7
In Silico Study towards Repositioning of FDA-Approved Drug Candidates for Anticoronaviral Therapy: Molecular Docking, Molecular Dynamics and Binding Free Energy Calculations.计算机模拟研究:重新定位 FDA 批准的候选药物用于抗冠状病毒治疗:分子对接、分子动力学和结合自由能计算。
Molecules. 2022 Sep 14;27(18):5988. doi: 10.3390/molecules27185988.
8
studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AAR antagonists for the treatment of Parkinson's disease.作为潜在的 MAO-B 抑制剂/ AAR 拮抗剂,对天然产物样咖啡因衍生物进行研究,以治疗帕金森病。
J Integr Bioinform. 2022 Sep 19;19(4). doi: 10.1515/jib-2021-0027. eCollection 2022 Dec 1.
9
Cotton flower metabolites inhibit SARS-CoV-2 main protease.棉花花代谢产物抑制 SARS-CoV-2 主蛋白酶。
FEBS Open Bio. 2022 Oct;12(10):1886-1895. doi: 10.1002/2211-5463.13477. Epub 2022 Sep 17.
10
Antimicrobial Alkaloids from Marine-Derived Fungi as Drug Leads versus COVID-19 Infection: A Computational Approach to Explore their Anti-COVID-19 Activity and ADMET Properties.源自海洋真菌的抗菌生物碱作为抗 COVID-19 感染的药物先导物:探索其抗 COVID-19 活性和药物代谢动力学性质的计算方法
Evid Based Complement Alternat Med. 2022 Jul 8;2022:5403757. doi: 10.1155/2022/5403757. eCollection 2022.